Related Experiment Video
Updated: Jul 11, 2026

09:42
Generation of Murine Monoclonal Antibodies by Hybridoma Technology
Published on: January 2, 2017
Optimizing antibody production in batch hybridoma cell culture
K L McKinney1, R Dilwith, G Belfort
1Howard P. Isermann Department of Chemical Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Journal of Biotechnology
|May 15, 1995
Summary
Flow cytometry can monitor hybridoma cell antibody production. Surface immunofluorescence levels effectively select high-producing hybridoma cells and track culture productivity in batch cultures.
Area of Science:
- Biotechnology
- Cell Biology
- Immunology
Background:
- Optimizing hybridoma cell productivity is crucial for monoclonal antibody production.
- Effective screening and selection methods for high-producing hybridoma cultures are needed.
- Understanding the regulation of antibody production in hybridomas is essential.
Purpose of the Study:
- To investigate hybridoma cell behavior in batch culture using flow cytometry.
- To develop and validate a method for monitoring and selecting high-producing hybridoma cells.
- To correlate surface antibody fluorescence with specific antibody secretion rates.
Main Methods:
- Utilized flow cytometry to analyze hybridoma cell populations.
- Employed a simple model to explain antibody production data from batch cultures.
- Measured surface and intracellular antibody fluorescence levels.
Main Results:
- Surface antibody fluorescence closely mirrored the decreasing specific antibody secretion rate.
- Surface immunofluorescence levels proved effective for selecting high-producing hybridoma cells (ATCC HB124 and TIB138).
- Surface and intracellular antibody fluorescence correlated in cells with bimodal intracellular antibody distribution, with higher intracellular levels indicating greater secretion.
Conclusions:
- Surface immunofluorescence is a reliable indicator for selecting high-producing hybridoma cells and monitoring culture productivity.
- Intracellular antibody content is directly related to antibody secretion rates.
- These findings offer strategies for optimizing monoclonal antibody yield through improved cell selection and culture monitoring.
Related Concept Videos
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

